Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Organ Modelling
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Formulation
Enhancing Drug Stability & Exploring Novel Formulation Strategies
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Formulation & Delivery UK 2024
Drug Discovery
Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders
To honour Alzheimer's & Brain Awareness Month, this article will acknowledge Amphista Therapeutics' use of targeted protein degradation (TPD) to treat symptoms of neurological disorders.
Chemical Biology
New Class of Molecular Glues Could Reshape Cancer Drug Discovery
A research group at the University of Dundee discovered new molecular glues, expanding the targeted protein degradation field.
Target Discovery
Advancing Cervical Cancer Treatment: FDA Approves Roche's New Self-Collection Option for HPV Testing
The FDA approves a new self-collection test to detect human papillomavirus and identify women at risk for cervical cancer.
Molecular Drug Design
New Trailblazer Profluent Launches its AI-enabled OpenCRISPR-1 to Edit the Human Genome
Profluent successfully combined large language models (LLMs) and CRISPR for an open-source AI gene editing project which could reshape CRISPR treatment options.
.png)
Beyond Traditional Therapeutics: How Digital Therapeutics Reshape Neurological and Neuropsychiatric Treatments
Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.
Chemical Biology
From Screening to Success: How Molecular 'Super-Glue' SJ3149, Could Advance Cancer Treatments
Researchers at St Jude Children's Research Hospital used high throughput screening (HTS) to identify SJ3149, a molecular glue degrader. This small molecule demonstrated efficacy across a range of cancer types.
Molecular Drug Design
Novo Nordisk Foundation and NVIDIA to Launch a State-of-the-Art National AI Research Centre
Novo Nordisk and NVIDIA join forces to build an AI supercomputer which will be housed in Denmark's national centre for AI innovation.